{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:03:10Z","timestamp":1772337790792,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejca.2015.04.012","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T16:30:46Z","timestamp":1431448246000},"page":"1456-1466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years"],"prefix":"10.1016","volume":"51","author":[{"given":"Matejka","family":"Rebolj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ditte","family":"Ejegod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Preisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Rygaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsebeth","family":"Lynge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejca.2015.04.012_b0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrclinonc.2010.96","article-title":"Screening: HPV testing for cervical cancer: the good, the bad, and the ugly","volume":"7","author":"Castle","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl. 10","key":"10.1016\/j.ejca.2015.04.012_b0010","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.ejca.2015.04.012_b0015","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.012_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.012_b0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2015.04.012_b0030","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.01517-13","article-title":"The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening","volume":"51","author":"Heideman","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.012_b0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.04.012_b0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1471-2334-14-413","article-title":"HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system","volume":"14","author":"Bonde","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.ejca.2015.04.012_b0045","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jmoldx.2013.04.002","article-title":"Prevalence of Human Papillomavirus Infection in Unselected SurePath Samples Using the APTIMA HPV mRNA Assay","volume":"15","author":"Rebolj","year":"2013","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.012_b0050","doi-asserted-by":"crossref","first-page":"e86835","DOI":"10.1371\/journal.pone.0086835","article-title":"Disagreement between Human Papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening","volume":"9","author":"Rebolj","year":"2014","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.012_b0055","doi-asserted-by":"crossref","first-page":"e59765","DOI":"10.1371\/journal.pone.0059765","article-title":"Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay","volume":"8","author":"Preisler","year":"2013","journal-title":"PLOS ONE"},{"issue":"12","key":"10.1016\/j.ejca.2015.04.012_b0060","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2012.12.084","article-title":"Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark","volume":"31","author":"Goldman","year":"2013","journal-title":"Vaccine"},{"issue":"7 Suppl.","key":"10.1016\/j.ejca.2015.04.012_b0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ejca.2015.04.012_b0070","unstructured":"Danish Cancer Society. St\u00e6rk social slagside i HPV-vaccinationer. URL: http:\/\/www.cancer.dk\/Nyheder\/nyhedsartikler\/2011kv3\/socialulighedihpvvacciner.htm>; 2011 [last accessed: 9 September 2011]."},{"issue":"4","key":"10.1016\/j.ejca.2015.04.012_b0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2015.04.012_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.012_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/CEJ.0b013e3283498dbe","article-title":"Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review","volume":"21","author":"Rebolj","year":"2012","journal-title":"Eur J Cancer Prev"},{"issue":"7","key":"10.1016\/j.ejca.2015.04.012_b0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2015.04.012_b0095","first-page":"1439","article-title":"The Problem of False-Positive Human Papillomavirus DNA Tests in Cervical Screening","volume":"19","author":"Rebolj","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.012_b0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejca.2010.08.010","article-title":"False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definition","volume":"47","author":"Rebolj","year":"2011","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2015.04.012_b0105","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.ejca.2015.04.012_b0110","first-page":"1411","article-title":"Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I","volume":"20","author":"Wu","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.012_b0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/JCM.02147-10","article-title":"Aptima HPV E6\/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer","volume":"49","author":"Ratnam","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.012_b0120","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2014.10.014","article-title":"Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology","volume":"135","author":"Rebolj","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.012_b0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1470-2045(09)70385-7","article-title":"Benefits and risks of HPV testing in cervical cancer screening","volume":"11","author":"Castle","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.012_b0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.1991.350","article-title":"Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer","volume":"64","author":"van Oortmarssen","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.04.012_b0135","unstructured":"Engholm G, Ferlay J, Christensen N, et al. NORDCAN: cancer incidence, mortality, prevalence and prediction in the Nordic countries, Version 3.5. Association of the Nordic Cancer Registries. Danish Cancer Society (http:\/\/www.ancr.nu); 2014 [last accessed: 25 November 2014]."},{"issue":"2","key":"10.1016\/j.ejca.2015.04.012_b0140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ijc.28366","article-title":"How many cervical cancer cases can potentially be prevented using a more sensitive screening test at young age?","volume":"134","author":"de Kok","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2015.04.012_b0145","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2015.04.012_b0150","doi-asserted-by":"crossref","first-page":"g6223","DOI":"10.1136\/bmj.g6223","article-title":"Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study","volume":"349","author":"Castanon","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2015.04.012_b0155","doi-asserted-by":"crossref","first-page":"e5174","DOI":"10.1136\/bmj.e5174","article-title":"Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study","volume":"345","author":"Castanon","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ejca.2015.04.012_b0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"issue":"9446","key":"10.1016\/j.ejca.2015.04.012_b0165","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(04)17366-2","article-title":"Cervical screening in adolescents\u2013at least do no harm","volume":"364","author":"Szarewski","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.012_b0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/bjc.2012.256","article-title":"Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing","volume":"107","author":"Hendry","year":"2012","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.012_b0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1525-1438.2007.01113.x","article-title":"The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial","volume":"18","author":"Kitchener","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"19","key":"10.1016\/j.ejca.2015.04.012_b0180","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915003482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915003482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T13:26:31Z","timestamp":1537622791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915003482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0959804915003482"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.04.012","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}